Chapter

Psychiatrists and the Pharmaceutical Industry

Philip B. Mitchell

in Mental Health and Human Rights

Published on behalf of Oxford University Press

Published in print June 2012 | ISBN: 9780199213962
Published online February 2013 | e-ISBN: 9780191754500 | DOI: http://dx.doi.org/10.1093/med/9780199213962.003.0022
Psychiatrists and the Pharmaceutical Industry

Show Summary Details

Preview

Philip Mitchell examines the challenge to the reputation of psychiatry arising from its aberrant relationship with pharmaceutical companies. There has been public, media, and institutional concern about this relationship. Proceeding from the assumption that it is not the relationship per se but how it operates, the chapter considers how it is dysfunctional and may be reformed. The chapter reviews general literature on the relationship of doctors to industry, specific points of contact, why psychiatrists are in the dubious lead, and how various bodies are responding, through professional organizations, medical schools, medical journals, and pharmaceutical industry organizations. The challenge of integrity and transparency is one that affects credibility and confidence in the profession.

Chapter.  8608 words. 

Subjects: Psychiatry

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.